CAI Caris Life Sciences, Inc.

NASDAQ
$17.58

Caris Life Sciences, Inc. (CAI) Earnings News

Earnings press releases, previews and reviews for Caris Life Sciences, Inc. (CAI), newest first. Our most recent is review: Caris Life Sciences Beats and Raises Again as Volume Accelerates, but Margins and Cash Flow Absorb the Cost of Its Launch Cycle.

Wednesday November 4, 2026 7:46 PM ET
Caris Life Sciences Beats and Raises Again as Volume Accelerates, but Margins and Cash Flow Absorb the Cost of Its Launch Cycle
Earnings Whispers · Review
Wednesday November 4, 2026 4:05 PM ET
Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Tuesday October 27, 2026 3:37 PM ET
Caris Stock Tests Its Highs as Street Forecasts Lag the Raised Revenue Outlook
Earnings Whispers · Preview
Monday October 19, 2026 6:30 AM ET
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
Thursday October 15, 2026 8:30 AM ET
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Wednesday October 14, 2026 8:30 AM ET
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
Tuesday September 8, 2026 6:30 AM ET
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect
Wednesday September 2, 2026 8:30 AM ET
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
Thursday August 27, 2026 8:30 AM ET
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
Wednesday August 5, 2026 4:05 PM ET
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Thursday July 16, 2026 8:30 AM ET
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Tuesday July 14, 2026 8:30 AM ET
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Wednesday July 1, 2026 8:30 AM ET
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
Tuesday June 16, 2026 8:30 AM ET
Caris Life Sciences Announces Dual Listing on NYSE Texas
Monday June 8, 2026 8:30 AM ET
Caris Life Sciences Announces Share Repurchase Program
Tuesday May 26, 2026 8:30 AM ET
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing